Literature DB >> 34143250

[Diagnostics and treatment of statin-associated muscle symptoms].

Ursula Kassner, Stefanie Grunwald, Dominik Spira, Nikolaus Buchmann, Thomas Bobbert, Elisabetta Gazzerro, Tim Hollstein, Simone Spuler, Elisabeth Steinhagen-Thiessen1.   

Abstract

Statins are among the most frequently prescribed drugs in Germany. Their benefits in lowering cardiovascular risk are beyond dispute. Nevertheless, many patients complain of side effects from statin therapy, including statin-associated muscle symptoms (SAMS) in particular. Despite their relative frequency, it is difficult to objectively diagnose them, as the time until appearance of first symptoms, the nature of the complaints and the severity of muscle problems vary widely. This narrative review summarizes the causes of SAMS as well as new possibilities regarding their diagnosis and therapy.
© 2021. Springer Medizin Verlag GmbH, ein Teil von Springer Nature.

Entities:  

Keywords:  Creatine kinase; Genetic predisposition to disease; HMG CoA reductase; Myalgia; Myopathies

Mesh:

Substances:

Year:  2021        PMID: 34143250     DOI: 10.1007/s00108-021-01059-0

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  52 in total

1.  Another side to statin-related side effects.

Authors:  Hans Knoblauch; Verena Schoewel; Wolfram Kress; Adrian Rosada; Simone Spuler
Journal:  Ann Intern Med       Date:  2010-04-06       Impact factor: 25.391

2.  Role of genetics in the prediction of statin-associated muscle symptoms and optimization of statin use and adherence.

Authors:  Liam R Brunham; Steven Baker; Andrew Mammen; G B John Mancini; Robert S Rosenson
Journal:  Cardiovasc Res       Date:  2018-07-01       Impact factor: 10.787

Review 3.  Statin-associated myopathy and the quest for biomarkers: can we effectively predict statin-associated muscle symptoms?

Authors:  Danina M Muntean; Paul D Thompson; Alberico L Catapano; Mariusz Stasiolek; Jaroslaw Fabis; Paul Muntner; Maria-Corina Serban; Maciej Banach
Journal:  Drug Discov Today       Date:  2016-09-12       Impact factor: 7.851

4.  Lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients with familial hypercholesterolemia in Germany: The CaReHigh Registry.

Authors:  Nina Schmidt; Alexander Dressel; Tanja B Grammer; Ioanna Gouni-Berthold; Ulrich Julius; Ursula Kassner; Gerald Klose; Christel König; Wolfgang Koenig; Britta Otte; Klaus G Parhofer; Wibke Reinhard; Ulrike Schatz; Heribert Schunkert; Elisabeth Steinhagen-Thiessen; Anja Vogt; Ulrich Laufs; Winfried März
Journal:  Atherosclerosis       Date:  2018-10       Impact factor: 5.162

Review 5.  Treatment Options for Statin-Associated Muscle Symptoms.

Authors:  Ulrich Laufs; Hubert Scharnagl; Martin Halle; Eberhard Windler; Matthias Endres; Winfried März
Journal:  Dtsch Arztebl Int       Date:  2015-10-30       Impact factor: 5.594

Review 6.  Lovastatin and beyond: the history of the HMG-CoA reductase inhibitors.

Authors:  Jonathan A Tobert
Journal:  Nat Rev Drug Discov       Date:  2003-07       Impact factor: 84.694

7.  Cholesterol target value attainment and lipid-lowering therapy in patients with stable or acute coronary heart disease: Results from the Dyslipidemia International Study II.

Authors:  Anselm K Gitt; Dominik Lautsch; Jean Ferrières; Gaetano M De Ferrari; Ami Vyas; Carl A Baxter; Lori D Bash; Veronica Ashton; Martin Horack; Wael Almahmeed; Fu-Tien Chiang; Kian Keong Poh; Philippe Brudi; Baishali Ambegaonkar
Journal:  Atherosclerosis       Date:  2017-08-21       Impact factor: 5.162

8.  Effect of statins on skeletal muscle function.

Authors:  Beth A Parker; Jeffrey A Capizzi; Adam S Grimaldi; Priscilla M Clarkson; Stephanie M Cole; Justin Keadle; Stuart Chipkin; Linda S Pescatello; Kathleen Simpson; C Michael White; Paul D Thompson
Journal:  Circulation       Date:  2012-11-26       Impact factor: 29.690

9.  N-of-1 Trial of a Statin, Placebo, or No Treatment to Assess Side Effects.

Authors:  Frances A Wood; James P Howard; Judith A Finegold; Alexandra N Nowbar; David M Thompson; Ahran D Arnold; Christopher A Rajkumar; Susan Connolly; Jaimini Cegla; Chris Stride; Peter Sever; Christine Norton; Simon A M Thom; Matthew J Shun-Shin; Darrel P Francis
Journal:  N Engl J Med       Date:  2020-11-15       Impact factor: 91.245

10.  SLCO1B1 rs4149056 polymorphism associated with statin-induced myopathy is differently distributed according to ethnicity in the Brazilian general population: Amerindians as a high risk ethnic group.

Authors:  Paulo C J L Santos; Renata A G Soares; Raimundo M Nascimento; George L L Machado-Coelho; José G Mill; José E Krieger; Alexandre C Pereira
Journal:  BMC Med Genet       Date:  2011-10-12       Impact factor: 2.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.